Neoadjuvant Therapy Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Supervised Physical Activity in Young Women With Early Breast Cancer During Neoadjuvant Chemotherpy
Conditions: Breast Cancer Interventions: Other: High Intensity Interval Training (HIIT); Drug: neoadjuvant treatment (doxorubicin, cyclophosphamide, paclitaxel, trastuzumab, pertuzumab) Sponsors: The Greater Poland Cancer Centre Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 4, 2024 Category: Research Source Type: clinical trials

Lumeneye Rectoscope for Assessment on Tumor Response After Total Neoadjuvant Treatment in Rectal Cancer
Conditions: Rectal Cancer Interventions: Device: International Cohort Sponsors: Bordeaux Colorectal Institute Academy Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 4, 2024 Category: Research Source Type: clinical trials

Follow up Study of Crocin on Cardiac Function Protection in Patients With Breast Cancer Undergoing Neoadjuvant Chemotherapy Based on Color Doppler Ultrasound Combined With Myocardial Zymogram
Conditions: Breast Cancer Interventions: Drug: Crocin Sponsors: Mei Zhang Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 3, 2024 Category: Research Source Type: clinical trials

DV in Combination With Pertuzumab With or Without Toripalimab Neoadjuvant Therapy With HER2-positive Breast Cancer
Conditions: Breast Cancer Interventions: Drug: Disitamab Vedotin Injection; Drug: Pertuzumab Injection; Drug: Toripalimab Sponsors: RemeGen Co., Ltd. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 20, 2023 Category: Research Source Type: clinical trials

Adbelizumab Combined With Chemotherapy for Neoadjuvant Therapy in Resectable Pancreatic Cancer
Conditions: Pancreatic Cancer; Neoadjuvant Therapy Interventions: Drug: Adbelimumab; Drug: albumin-bound paclitaxel; Drug: Gemcitabine Sponsors: Jinling Hospital, China; Jiangsu Hengrui Pharmaceutical Co., Ltd. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 20, 2023 Category: Research Source Type: clinical trials

Neoadjuvant Adebrelimab Plus Chemotherapy for Resectable ESCC: a Single Arm, Prospective Phase 2 Clinical Trial
Conditions: Esophageal Squamous Cell Carcinoma Interventions: Drug: Immunotherapy: Adebrelimab; Drug: chemotherapy: carboplatin plus nab-paclitaxel Sponsors: Shanghai Chest Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 20, 2023 Category: Research Source Type: clinical trials

Assessing the Clinical Utility of Adding Pentoxifylline to Neoadjuvant Chemotherapy Protocols in Breast Cancer Patients "
Conditions: Breast Cancer Female Interventions: Drug: Pentoxifylline Oral Tablet; Drug: Placebo Sponsors: Mansoura University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 19, 2023 Category: Research Source Type: clinical trials

Two Phase 3 Trials of Datopotamab Deruxtecan Plus Durvalumab Initiated in Patients Across Two Breast Cancer Subtypes
TROPION-Breast04 is evaluating Daiichi Sankyo and AstraZeneca’s datopotamab deruxtecan plus durvalumab as neoadjuvant treatment for early-stage triple negative and HR low, HER2 low or negative breast cancers TROPION-Breast05 is evaluating... (Source: Drugs.com - Clinical Trials)
Source: Drugs.com - Clinical Trials - December 18, 2023 Category: Pharmaceuticals Source Type: clinical trials

DCE-MRI Guided Neoadjuvant Chemotherapy for Borderline Resectable Pancreatic Cancer
Conditions: Borderline-resectable Pancreatic Cancer Interventions: Device: Point-of-care Portable Perfusion Phantom (P4) Sponsors: University of Alabama at Birmingham Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 15, 2023 Category: Research Source Type: clinical trials

Irinotecan Liposome for Resectable Pancreatic Cancer With or Without Addebelizumab
Conditions: Neoadjuvant Chemotherapy; Resectable Pancreatic Cancer Interventions: Drug: irinotecan liposome + oxaliplatin + 5-FU / LV; Drug: Adebellizumab Sponsors: Zhejiang University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 15, 2023 Category: Research Source Type: clinical trials

An Observational Study to Evaluate Neoadjuvant Nivolumab (OPDIVO ®) in Combination With Platinum-Based Chemotherapy in Non-Metastatic Non-Small Cell Lung Cancer Participants in Germany
Conditions: Resectable Non-small Cell Lung Cancer Interventions: Drug: Neoadjuvant nivolumab in combination with platinum-based chemotherapy Sponsors: Bristol-Myers Squibb Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 14, 2023 Category: Research Source Type: clinical trials

Ramucirumab Combined With Nab-paclitaxel, Lobaplatin, and S-1 in Neoadjuvant Transformation Therapy for Advanced Gastric Cancer
Conditions: Advanced Gastric Cancer Interventions: Drug: Ramucirumab; Drug: lobaplatin, S-1 and nab-paclitaxel Sponsors: Yang Jianjun, PhD Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 13, 2023 Category: Research Source Type: clinical trials

Stereotactic Radiotherapy Combined With Adebrelimab and TCb (Nab-paclitaxel + Carboplatin) in Neoadjuvant Treatment of TNBC
Conditions: Stereotactic Radiotherapy; Immunotherapy; Breast Cancer Interventions: Drug: adebrelimab plus stereotactic radiotherapy followed by adebrelimab plus chemotherapy (nab-paclitaxel + carboplatin); Drug: adebrelimab plus chemotherapy (nab-paclitaxel + carboplatin) Sponsors: Shengjing Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 12, 2023 Category: Research Source Type: clinical trials

Cardenilimab Combined With Chemotherapy for Locally Advanced Esophageal Squamous Cell Carcinoma:A Prospective, Multicenter, Phase II Study
Conditions: Esophageal Squamous Cell Carcinoma; Neoadjuvant Therapies Interventions: Drug: Cardenilimab Combined With Chemotherapy Sponsors: Li Zhang Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 11, 2023 Category: Research Source Type: clinical trials

Cardenilimab Combined With Chemotherapy for Locally Advanced Esophageal Squamous Cell Carcinoma
Conditions: Esophageal Squamous Cell Carcinoma; Neoadjuvant Therapies Interventions: Drug: Cardenilimab Combined With Chemotherapy Sponsors: Li Zhang Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 11, 2023 Category: Research Source Type: clinical trials